MedWatch

Former Eli Lilly and Sanofi exec to establish pain killer empire

Danish researcher Philip Just Larsen has conducted diabetes research for companies like Novo Nordisk, Sanofi and Eli Lilly. Now, he is CSO in German Grünenthal and aims to develop the future's pain killers and maybe even find a solution to the deadly opioid addiction.

Foto: Grünenthal

When Philip Just Larsen took position as CSO in German pharmaceutical company Grünenthal it also marked the end of more than 20 years long career in diabetes research.

The Danish researcher was responsible for several of Novo Nordisk's early liraglutide studies, which later resulted in the drugs Victoza and Saxenda. He led the diabetes research at Eli Lilly while the company developed the best-seller Trulicity, and until the spring he served as Global Head of Diabetes R&D at Sanofi.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier